SCD and breast carcinoma: Accordingly, it is reported that FADS expression and activity determine ferroptosis sensitivity in gastric and ovarian cancer (Lee et al, 2020; Xuan et al, 2022), whereas those of SCD sustain ferroptosis resistance in breast cancer (Luis et al, 2021), reinforcing the idea that PUFA intracellular availability is necessary for ferroptosis execution.